Search results
18 cze 2018 · REAL-CAD (Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease) is currently the largest randomized trial to compare high-dose and low-dose statin therapy. It was also the first such trial performed in Asia.
13 lis 2017 · The REAL-CAD trial showed that high-dose pitavastatin 4 mg/day is superior to low-dose pitavastatin 1 mg/day in reducing adverse cardiovascular events among patients with established stable CAD.
The REAL-CAD (Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy with Pitavastatin in Coronary Artery Disease) study demonstrated the benefit of higher intensity pitavastatin in Japanese patients with CCS.
Gaming PCs are pretty much ideal AutoCAD machines. When I build a AutoCAD box, I basically build a gaming PC with a slightly cheaper video card than processor. That will vary depending on exactly what kind of design you are doing.
REAL-CAD (Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavas-tatin in Coronary Artery Disease) is currently the largest randomized trial to compare high-dose and low-dose statin therapy. It was also the first such trial performed in Asia.
8 maj 2018 · High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial Circulation. 2018 May 8;137(19) :1997-2009. ... Results: The mean age of the study population was 68 years, and 83% were male. The mean LDL-C level before enrollment was 93 mg/dL with 91% of patients taking ...
This prespecified subanalysis of the REAL-CAD study aimed to assess the prognostic effect of the persistent low-grade inflammation represented by high-sensitivity C-reactive protein (hs-CRP) in CCS patients.
